Literature DB >> 9474065

Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy.

P Stanzione1, R Semprini, M Pierantozzi, A M Santilli, L Fadda, R Traversa, A Peppe, G Bernardi.   

Abstract

Acoustic P300 was recorded from Fz, Cz and Pz by means of an 'odd-ball' paradigm in 44 non-demented de novo Parkinson's disease patients (PD) or PD patients under treatment withdrawal, and in 31 age-matched normal subjects, to evaluate whether a P300 latency increase was present in PD patients. The influence of age and disease stage on latency was successively verified by subgrouping PD patients according to different age ('young' and 'old') and disease stage ('early' or 'advanced'). PD patient data were compared to data of normal subjects subgrouped into 'young' and 'old' or, to eliminate the age-dependent shift of latency, this latter was adjusted to 60 years in all the examined subjects. A significant increase of latency has been found in Fz and Cz in the 'old' group of PD patients (n = 23) but not in the 'young' group (n = 21) utilising both methods. Moreover, a significant latency increase was also present in Fz and Cz in the group of 'advanced' PD patients (n = 8), but not in the group of 'early' PD patients (n = 36) utilising age-adjusted measurements. When the 'early' PD patient group was divided into 'young' (n = 20) and 'old' (n = 16), the 'early old' group displayed significantly increased latencies in Fz compared with normal subjects. Abnormal P300 latencies were observed, at least in one electrode, by analysing the raw data, in 5.0% of the 'early young', 43.7% of the 'early old' and up to 62.7% of the 'advanced' patients. Fz represented the site in which abnormal P300 latencies were most often observed. Moreover, in the total group of PD patients, the P300 delay was significant only on the frontal (Fz) site when compared with normal subjects. The reported findings were interpreted as if PD produces a sort of 'accelerated effect of age' on the cognitive functions, presumably produced by a mechanism different from that producing motor impairment since no clear correlation could be detected between P300 latency and motor score. The frontal impairment of P300 is in line with previous neuropsychological findings obtained in these patients. Considering that about 30% of PD patients develop dementia during their disease progression, a border-line or abnormal P300 latency observed at disease onset may represent a predictive marker of this evolution.

Entities:  

Mesh:

Year:  1998        PMID: 9474065     DOI: 10.1016/s0168-5597(97)00070-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  6 in total

1.  Effect of interstimulus interval on visual P300 in Parkinson's disease.

Authors:  L Wang; Y Kuroiwa; T Kamitani; T Takahashi; Y Suzuki; O Hasegawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 3.  N200 and P300 component changes in Parkinson's disease: a meta-analysis.

Authors:  Hui Xu; Lihua Gu; Shiyao Zhang; Yuchen Wu; Xiaojin Wei; Caiyan Wang; Yuhan Xu; Yijing Guo
Journal:  Neurol Sci       Date:  2022-08-18       Impact factor: 3.830

4.  Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease.

Authors:  Fikriye Tüter Yilmaz; Sehür Siber Özkaynak; Ebru Barçin
Journal:  Neurol Sci       Date:  2017-09-08       Impact factor: 3.307

5.  Role of basal ganglia circuits in resisting interference by distracters: a swLORETA study.

Authors:  Perrine Bocquillon; Jean-Louis Bourriez; Ernesto Palmero-Soler; Alain Destée; Luc Defebvre; Philippe Derambure; Kathy Dujardin
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Electrophysiological Evidence of Auditory and Cognitive Processing Deficits in Parkinson Disease.

Authors:  Robert L Folmer; Jay J Vachhani; Amy Riggins
Journal:  Biomed Res Int       Date:  2021-06-18       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.